111 related articles for article (PubMed ID: 7925856)
1. Partial characterization of human leukemia U-937 cell sublines resistant to 9-nitrocamptothecin.
Pantazis P; Mendoza JT; DeJesus A; Rubin E; Kufe D; Giovanella BC
Eur J Haematol; 1994 Sep; 53(3):135-44. PubMed ID: 7925856
[TBL] [Abstract][Full Text] [Related]
2. Sensitivity of camptothecin-resistant human leukemia cells and tumors to anticancer drugs with diverse mechanisms of action.
Pantazis P; Vardeman D; Mendoza J; Early J; Kozielski A; DeJesus A; Giovanella B
Leuk Res; 1995 Jan; 19(1):43-55. PubMed ID: 7837817
[TBL] [Abstract][Full Text] [Related]
3. 9-Nitro-camptothecin delays growth of U-937 leukemia tumors in nude mice and is cytotoxic or cytostatic for human myelomonocytic leukemia lines in vitro.
Pantazis P; Mendoza JT; Early JA; Kozielski AJ; Natelson EA; Giovanella BC
Eur J Haematol; 1993 Feb; 50(2):81-9. PubMed ID: 8440362
[TBL] [Abstract][Full Text] [Related]
4. Development of resistance to 9-nitro-camptothecin by human leukemia U-937 cells in vitro correlates with altered sensitivities to several anticancer drugs.
Pantazis P; Mendoza J; DeJesus A; Early J; Shaw M; Giovanella BC
Anticancer Drugs; 1994 Aug; 5(4):473-9. PubMed ID: 7949254
[TBL] [Abstract][Full Text] [Related]
5. Camptothecin and 9-nitrocamptothecin (9NC) as anti-cancer, anti-HIV and cell-differentiation agents. Development of resistance, enhancement of 9NC-induced activities and combination treatments in cell and animal models.
Pantazis P; Han Z; Balan K; Wang Y; Wyche JH
Anticancer Res; 2003; 23(5A):3623-38. PubMed ID: 14666658
[TBL] [Abstract][Full Text] [Related]
6. Induction of apoptosis in malignant and camptothecin-resistant human cells.
Chatterjee D; Wyche JH; Pantazis P
Ann N Y Acad Sci; 1996 Dec; 803():143-56. PubMed ID: 8993507
[TBL] [Abstract][Full Text] [Related]
7. Induction of senescent cell-derived inhibitor of DNA synthesis gene, SDI1, in hepatoblastoma (HepG2) cells arrested in the G2-phase of the cell cycle by 9-nitrocamptothecin.
Khaoustov VI; Ozer A; Smith JR; Noda A; Mearns M; Krishnan B; Slagle BL; Yoffe B
Lab Invest; 1995 Jul; 73(1):118-27. PubMed ID: 7603034
[TBL] [Abstract][Full Text] [Related]
8. 9-nitrocamptothecin selectively inhibits human immunodeficiency virus type 1 replication in freshly infected parental but not 9-nitrocamptothecin-resistant U937 monocytoid cells.
Sadaie MR; Doniger J; Hung CL; Pantazis P
AIDS Res Hum Retroviruses; 1999 Feb; 15(3):239-45. PubMed ID: 10052754
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxic efficacy of 9-nitrocamptothecin in the treatment of human malignant melanoma cells in vitro.
Pantazis P; Early JA; Mendoza JT; DeJesus AR; Giovanella BC
Cancer Res; 1994 Feb; 54(3):771-6. PubMed ID: 8306340
[TBL] [Abstract][Full Text] [Related]
10. Regression of human breast carcinoma tumors in immunodeficient mice treated with 9-nitrocamptothecin: differential response of nontumorigenic and tumorigenic human breast cells in vitro.
Pantazis P; Early JA; Kozielski AJ; Mendoza JT; Hinz HR; Giovanella BC
Cancer Res; 1993 Apr; 53(7):1577-82. PubMed ID: 8453626
[TBL] [Abstract][Full Text] [Related]
11. Propionate and butyrate esters of camptothecin and 9-nitrocamptothecin as antileukemia prodrugs in vitro.
Han Z; Cao Z; Chatterjee D; Wyche J; Pantazis P
Eur J Haematol; 1999 Apr; 62(4):246-55. PubMed ID: 10227458
[TBL] [Abstract][Full Text] [Related]
12. Acquisition of cellular resistance to 9-nitro-camptothecin correlates with suppression of transcription factor NF-kappa B activation and potentiation of cytotoxicity by tumor necrosis factor in human histiocytic lymphoma U-937 cells.
Singh S; Raju U; Mendoza J; Pantazis P; Aggarwal BB
Anticancer Drugs; 1998 Sep; 9(8):703-14. PubMed ID: 9823429
[TBL] [Abstract][Full Text] [Related]
13. Establishment of human prostate tumor xenografts in nude mice and response to 9-nitrocamptothecin in vivo and in vitro does not correlate with the expression of various apoptosis-regulating proteins.
Pantazis P; Chatterjee D; Wyche J; DeJesus A; Early J; Plaschke S; Giovanella B
J Exp Ther Oncol; 1996 Sep; 1(5):322-33. PubMed ID: 9414421
[TBL] [Abstract][Full Text] [Related]
14. Modulation of 9-nitrocamptothecin-induced apoptosis by hyperthermia in human leukemia HL-60 cells.
Pantazis P; Chatterjee D; Han Z; Wyche J
Anticancer Drugs; 1999 Mar; 10(3):317-22. PubMed ID: 10327039
[TBL] [Abstract][Full Text] [Related]
15. Reduction of 9-nitrocamptothecin-triggered apoptosis in DU-145 human prostate cancer cells by ectopic expression of 14-3-3zeta.
Chatterjee D; Goldman M; Braastad CD; Darnowski J; Wyche JH; Pantazis P; Goodglick L
Int J Oncol; 2004 Aug; 25(2):503-9. PubMed ID: 15254750
[TBL] [Abstract][Full Text] [Related]
16. Development of human leukemia U-937 cell sublines resistant to doxorubicin: induction of differentiation and altered sensitivities to topoisomerase-directed drugs.
Pantazis P; Dejesus A; Early J; Rodriguez R; Chatterjee D; Han Z; Wyche J; Giovanella B
Anticancer Res; 1995; 15(5B):1873-81. PubMed ID: 8572572
[TBL] [Abstract][Full Text] [Related]
17. Differentiation of human malignant melanoma cells that escape apoptosis after treatment with 9-nitrocamptothecin in vitro.
Pantazis P; Chatterjee D; Han Z; Wyche J
Neoplasia; 1999 Aug; 1(3):231-40. PubMed ID: 10935478
[TBL] [Abstract][Full Text] [Related]
18. Camptothecin derivatives induce regression of human ovarian carcinomas grown in nude mice and distinguish between non-tumorigenic and tumorigenic cells in vitro.
Pantazis P; Kozielski AJ; Mendoza JT; Early JA; Hinz HR; Giovanella BC
Int J Cancer; 1993 Mar; 53(5):863-71. PubMed ID: 8449612
[TBL] [Abstract][Full Text] [Related]
19. Monocytic differentiation and synthesis of proteins associated with apoptosis in human leukemia U-937 cells acquiring resistance to vincristine.
Pantazis P; Chatterjee D; Han Z; Wyche J; DeJesus A; Giovanella B
Eur J Haematol; 1996 Jul; 57(1):79-86. PubMed ID: 8698136
[TBL] [Abstract][Full Text] [Related]
20. 9-Nitrocamptothecin inhibits tumor recrosis factor-mediated activation of human immunodeficiency virus type 1 and enhances apoptosis in a latently infected T cell clone.
Moulton S; Pantazis P; Epstein JS; Sadaie MR
AIDS Res Hum Retroviruses; 1998 Jan; 14(1):39-49. PubMed ID: 9453250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
